Medicine Man Technologies, Inc. Share Price Other OTC
Equities
SHWZ
US58468U1060
Pharmaceuticals
Sales 2024 * | 17Cr 1.45TCr | Sales 2025 * | 19Cr 1.6TCr | Capitalization | 4.38Cr 364.6Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.25 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.23 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.43% |
Latest transcript on Medicine Man Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 16/23/16 | |
Justin Dye
CHM | Chairman | 52 | 05/19/05 |
Ed Eissenstat
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathy Vrabeck
BRD | Director/Board Member | 60 | 02/11 |
Jeffrey Cozad
BRD | Director/Board Member | 60 | 15/21/15 |
Marc Rubin
BRD | Director/Board Member | 50 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+43.31% | 619.29Cr | |
-16.99% | 447.8Cr | |
+6.39% | 329.47Cr | |
-13.10% | 311.62Cr | |
-4.17% | 249.56Cr | |
+45.47% | 193.95Cr | |
-9.11% | 168.48Cr | |
-2.09% | 163.72Cr | |
-12.50% | 156.14Cr |